BioMarin Pharmaceuticals BMRN Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's common stock, shares authorized (in shares)?
- BioMarin Pharmaceuticals (BMRN) reported common stock, shares authorized (in shares) of $500M in Q1 2026.
- How has BioMarin Pharmaceuticals's common stock, shares authorized (in shares) changed year-over-year?
- BioMarin Pharmaceuticals's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $500M to $500M.
- What is the long-term trend for BioMarin Pharmaceuticals's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $500M to $500M.